Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Otorhinolaryngology

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    November 2018
  1. YAO JJ, Zhang F, Gao TS, Zhang WJ, et al
    Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Radiother Oncol. 2018 Nov 14. pii: S0167-8140(18)33542.
    PubMed     Text format     Abstract available


  2. TOPKAN E, Yildirim BA
    Epoetin receptor status may alter the outcomes in head and neck cancers treated with radiotherapy and darbepoetin-alpha.
    Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33397.
    PubMed     Text format    


    October 2018
  3. LIANG SB, Zhang N, Chen DM, Yang XL, et al
    Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
    Radiother Oncol. 2018 Oct 23. pii: S0167-8140(18)33522.
    PubMed     Text format     Abstract available


  4. YILMAZ MT, Elmali A, Yazici G
    Comments on "High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer".
    Radiother Oncol. 2018 Oct 17. pii: S0167-8140(18)33506.
    PubMed     Text format    


  5. KANAYAMA N, Kierkels RGJ, van der Schaaf A, Steenbakkers RJHM, et al
    External validation of a multifactorial normal tissue complication probability model for tube feeding dependence at 6months after definitive radiotherapy for head and neck cancer.
    Radiother Oncol. 2018 Oct 6. pii: S0167-8140(18)33496.
    PubMed     Text format     Abstract available


    September 2018
  6. HUANG XD, Zhou GQ, Lv JW, Zhou HQ, et al
    Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
    Radiother Oncol. 2018 Sep 27. pii: S0167-8140(18)33487.
    PubMed     Text format     Abstract available


  7. OVERGAARD J, Alsner J
    Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC).
    Radiother Oncol. 2018 Sep 21. pii: S0167-8140(18)33452.
    PubMed     Text format    


  8. BIAU J, Dunet V, Lapeyre M, Simon C, et al
    Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.
    Radiother Oncol. 2018 Sep 8. pii: S0167-8140(18)33458.
    PubMed     Text format     Abstract available


  9. KAMAL M, Mohamed ASR, Volpe S, Zaveri J, et al
    Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
    Radiother Oncol. 2018;128:442-451.
    PubMed     Text format     Abstract available


  10. DIXON L, Ramasamy S, Cardale K, Dyker K, et al
    Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Radiother Oncol. 2018;128:452-458.
    PubMed     Text format     Abstract available


    August 2018
  11. OU D, Adam J, Garberis I, Blanchard P, et al
    Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy.
    Radiother Oncol. 2018 Aug 29. pii: S0167-8140(18)33451.
    PubMed     Text format     Abstract available


  12. DE VEIJ MESTDAGH PD, Janssen T, Lamers E, Carbaat C, et al
    SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
    Radiother Oncol. 2018 Aug 4. pii: S0167-8140(18)33422.
    PubMed     Text format     Abstract available


  13. LEGER S, Zwanenburg A, Pilz K, Zschaeck S, et al
    CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.
    Radiother Oncol. 2018 Aug 4. pii: S0167-8140(18)33419.
    PubMed     Text format     Abstract available


  14. LI YJ, Luo Y, Xie XQ, Li P, et al
    The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
    Radiother Oncol. 2018 Aug 3. pii: S0167-8140(18)33421.
    PubMed     Text format     Abstract available


    July 2018
  15. NOBLE DJ, Yeap PL, Seah SYK, Harrison K, et al
    Anatomical change during radiotherapy for head and neck cancer, and its effect on delivered dose to the spinal cord.
    Radiother Oncol. 2018 Jul 23. pii: S0167-8140(18)33396.
    PubMed     Text format     Abstract available


  16. VAN DEN BOSCH S, Dijkema T, Philippens MEP, Terhaard CHJ, et al
    Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of (18)F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.
    Radiother Oncol. 2018 Jul 10. pii: S0167-8140(18)33352.
    PubMed     Text format     Abstract available


  17. NAVRAN A, Heemsbergen W, Janssen T, Hamming-Vrieze O, et al
    The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
    Radiother Oncol. 2018 Jul 10. pii: S0167-8140(18)33347.
    PubMed     Text format     Abstract available


    May 2018
  18. TAO Y, Faivre L, Laprie A, Boisselier P, et al
    Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
    Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30246.
    PubMed     Text format     Abstract available


  19. WINTER RM, Leibfarth S, Schmidt H, Zwirner K, et al
    Assessment of image quality of a radiotherapy-specific hardware solution for PET/MRI in head and neck cancer patients.
    Radiother Oncol. 2018 May 7. pii: S0167-8140(18)30209.
    PubMed     Text format     Abstract available


  20. MICHIELS S, Poels K, Crijns W, Delombaerde L, et al
    Volumetric modulated arc therapy of head-and-neck cancer on a fast-rotating O-ring linac: Plan quality and delivery time comparison with a C-arm linac.
    Radiother Oncol. 2018 May 5. pii: S0167-8140(18)30212.
    PubMed     Text format     Abstract available


  21. VAN DEN BOSCH S, Vogel WV, Raaijmakers CP, Dijkema T, et al
    Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.
    Radiother Oncol. 2018 May 3. pii: S0167-8140(18)30211.
    PubMed     Text format     Abstract available


  22. DELANEY AR, Dahele M, Slotman BJ, Verbakel WFAR, et al
    Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans?
    Radiother Oncol. 2018;127:190-196.
    PubMed     Text format     Abstract available


    April 2018
  23. MURTHY V, Lewis S, Kannan S, Khadanga CR, et al
    Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study.
    Radiother Oncol. 2018 Apr 30. pii: S0167-8140(18)30113.
    PubMed     Text format     Abstract available


  24. GREGOIRE V, Grau C
    In reply to "A Long-Awaited Guideline for the Delineation of Primary Tumor in Head and Neck Cancer, and a Few Concerns about It" by Sezin Yuce Sari et al.
    Radiother Oncol. 2018 Apr 27. pii: S0167-8140(18)30175.
    PubMed     Text format    


  25. YUCE SARI S, Yeginer M, Cengiz M
    A long-awaited guideline for the delineation of primary tumor in head and neck cancer, and a few concerns about it.
    Radiother Oncol. 2018 Apr 24. pii: S0167-8140(18)30177.
    PubMed     Text format    


    March 2018
  26. TAN TH, Soon YY, Cheo T, Ho F, et al
    Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
    Radiother Oncol. 2018 Mar 16. pii: S0167-8140(18)30123.
    PubMed     Text format     Abstract available


  27. SHURYAK I, Hall EJ, Brenner DJ
    Dose dependence of accelerated repopulation in head and neck cancer: Supporting evidence and clinical implications.
    Radiother Oncol. 2018 Mar 10. pii: S0167-8140(18)30098.
    PubMed     Text format     Abstract available


  28. FANG P, Jiang W, Davuluri R, Xu C, et al
    High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer.
    Radiother Oncol. 2018 Mar 9. pii: S0167-8140(18)30117.
    PubMed     Text format     Abstract available


  29. OVERGAARD J, Hoff CM, Hansen HS, Specht L, et al
    DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
    Radiother Oncol. 2018 Mar 6. pii: S0167-8140(18)30105.
    PubMed     Text format     Abstract available


  30. HE J, Cai L, Chen Y, He Y, et al
    Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
    Radiother Oncol. 2018 Mar 5. pii: S0167-8140(18)30063.
    PubMed     Text format     Abstract available


    January 2018
  31. IQBAL MS, Kelly C, Kovarik J, Goranov B, et al
    Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A survey of UK national practice.
    Radiother Oncol. 2018 Jan 20. pii: S0167-8140(17)32734.
    PubMed     Text format    


  32. SHAHID IQBAL M, Kelly C, Kovarik J, Goranov B, et al
    Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review.
    Radiother Oncol. 2018 Jan 19. pii: S0167-8140(17)32766.
    PubMed     Text format     Abstract available


  33. PAULINO AC, Mahajan A, Ye R, Grosshans DR, et al
    Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
    Radiother Oncol. 2018 Jan 17. pii: S0167-8140(18)30017.
    PubMed     Text format     Abstract available


  34. ADENIS A, Castan F, Conroy T
    Consolidation chemotherapy after definite concurrent chemoradiation in patients with non-operable esophageal cancer: Is it useful?
    Radiother Oncol. 2018 Jan 10. pii: S0167-8140(17)32773.
    PubMed     Text format    


  35. CHEN Y, Wang J
    Concurrent chemoradiotherapy alone is feasible for esophageal squamous cell carcinoma patients not suitable for surgery.
    Radiother Oncol. 2018 Jan 10. pii: S0167-8140(17)32774.
    PubMed     Text format    


  36. NEVENS D, Duprez F, Bonte K, Deron P, et al
    Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Reply to Elicin et al.
    Radiother Oncol. 2018 Jan 4. pii: S0167-8140(17)32770.
    PubMed     Text format    


  37. GREGOIRE V, Evans M, Le QT, Bourhis J, et al
    Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Onc
    Radiother Oncol. 2018;126:3-24.
    PubMed     Text format     Abstract available


  38. HANSEN CR, Johansen J, Samsoe E, Andersen E, et al
    Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
    Radiother Oncol. 2018;126:43-47.
    PubMed     Text format     Abstract available


  39. LASSEN P, Lacas B, Pignon JP, Trotti A, et al
    Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project.
    Radiother Oncol. 2018;126:107-115.
    PubMed     Text format     Abstract available


    December 2017
  40. ZHANG Y, Li WF, Liu X, Chen L, et al
    Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial.
    Radiother Oncol. 2017 Dec 16. pii: S0167-8140(17)32756.
    PubMed     Text format     Abstract available


  41. SHIRAISHI Y, Fang P, Xu C, Song J, et al
    Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
    Radiother Oncol. 2017 Dec 13. pii: S0167-8140(17)32751.
    PubMed     Text format     Abstract available


  42. KAMAL M, Rosenthal DI, Volpe S, Goepfert RP, et al
    Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.
    Radiother Oncol. 2017 Dec 8. pii: S0167-8140(17)32691.
    PubMed     Text format     Abstract available


    November 2017
  43. LEE AW, Ng WT, Pan JJ, Poh SS, et al
    International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.
    Radiother Oncol. 2017 Nov 15. pii: S0167-8140(17)32686.
    PubMed     Text format     Abstract available


  44. BOGOWICZ M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, et al
    Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
    Radiother Oncol. 2017 Nov 6. pii: S0167-8140(17)32663.
    PubMed     Text format     Abstract available


  45. TAKAHASHI N, Umezawa R, Takanami K, Yamamoto T, et al
    Whole-body total lesion glycolysis is an independent predictor in patients with esophageal cancer treated with definitive chemoradiotherapy.
    Radiother Oncol. 2017 Nov 3. pii: S0167-8140(17)32659.
    PubMed     Text format     Abstract available


    October 2017
  46. CEREDA E, Cappello S, Colombo S, Klersy C, et al
    Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy.
    Radiother Oncol. 2017 Oct 27. pii: S0167-8140(17)32655.
    PubMed     Text format     Abstract available


  47. OU D, Garberis I, Adam J, Blanchard P, et al
    Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
    Radiother Oncol. 2017 Oct 24. pii: S0167-8140(17)32647.
    PubMed     Text format     Abstract available


  48. DE-COLLE C, Menegakis A, Monnich D, Welz S, et al
    SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
    Radiother Oncol. 2017 Oct 20. pii: S0167-8140(17)32648.
    PubMed     Text format     Abstract available


  49. RAO AD, Coquia S, De Jong R, Gourin C, et al
    Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers.
    Radiother Oncol. 2017 Oct 3. pii: S0167-8140(17)32584.
    PubMed     Text format     Abstract available


    September 2017
  50. MICHIELS S, Barragan AM, Souris K, Poels K, et al
    Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization.
    Radiother Oncol. 2017 Sep 23. pii: S0167-8140(17)32568.
    PubMed     Text format     Abstract available


  51. WOPKEN K, Bijl HP, Langendijk JA
    Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.
    Radiother Oncol. 2017 Sep 21. pii: S0167-8140(17)32545.
    PubMed     Text format     Abstract available


  52. CHANG CL, Tsai HC, Lin WC, Chang JH, et al
    Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
    Radiother Oncol. 2017 Sep 15. pii: S0167-8140(17)32548.
    PubMed     Text format     Abstract available


  53. SHIRAISHI Y, Xu C, Yang J, Komaki R, et al
    Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Radiother Oncol. 2017 Sep 13. pii: S0167-8140(17)32550.
    PubMed     Text format     Abstract available


    August 2017

  54. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
    Radiother Oncol. 2017;124:232-239.
    PubMed     Text format     Abstract available


  55. MAVROIDIS P, Price A, Fried D, Kostich M, et al
    Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
    Radiother Oncol. 2017;124:240-247.
    PubMed     Text format     Abstract available


  56. GUTTMANN DM, Frick MA, Carmona R, Deville C Jr, et al
    A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma.
    Radiother Oncol. 2017;124:271-276.
    PubMed     Text format     Abstract available


    June 2017
  57. ZHANG W, Zhang X, Yang P, Blanchard P, et al
    Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
    Radiother Oncol. 2017;123:401-405.
    PubMed     Text format     Abstract available


  58. CHEN AM, Chin R, Beron P, Yoshizaki T, et al
    Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer.
    Radiother Oncol. 2017;123:412-418.
    PubMed     Text format     Abstract available


    April 2017
  59. WU B, Kusters M, Kunze-Busch M, Dijkema T, et al
    Cross-institutional knowledge-based planning (KBP) implementation and its performance comparison to Auto-Planning Engine (APE).
    Radiother Oncol. 2017;123:57-62.
    PubMed     Text format     Abstract available


    March 2017
  60. NAKAMURA N, Zenda S, Tahara M, Okano S, et al
    Proton beam therapy for olfactory neuroblastoma.
    Radiother Oncol. 2017;122:368-372.
    PubMed     Text format     Abstract available


    February 2017
  61. HAMMING-VRIEZE O, van Kranen SR, Heemsbergen WD, Lange CA, et al
    Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy.
    Radiother Oncol. 2017;122:224-228.
    PubMed     Text format     Abstract available


  62. SODERSTROM K, Nilsson P, Laurell G, Zackrisson B, et al
    Dysphagia - Results from multivariable predictive modelling on aspiration from a subset of the ARTSCAN trial.
    Radiother Oncol. 2017;122:192-199.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: